Phase 4 Study of Randomized Comparison Among Oral Rapamycin [sirolimus] Plus Bare Metal Stents Versus Drug Eluting Stents in de Novo Coronary Lesions

Trial Profile

Phase 4 Study of Randomized Comparison Among Oral Rapamycin [sirolimus] Plus Bare Metal Stents Versus Drug Eluting Stents in de Novo Coronary Lesions

Completed
Phase of Trial: Phase IV

Latest Information Update: 03 Sep 2014

At a glance

  • Drugs Sirolimus (Primary) ; Sirolimus (Primary) ; Paclitaxel; Zotarolimus
  • Indications Coronary artery disease; Coronary artery restenosis
  • Focus Therapeutic Use
  • Acronyms ORAR-III
  • Most Recent Events

    • 11 Mar 2013 Final 5-year results presented at the 62nd Annual Scientific Session of the American College of Cardiology.
    • 07 Nov 2012 Four-year results presented at the 85th Annual Scientific Sessions of the American Heart Association.
    • 01 Sep 2012 Three-year results published in Catheterization and Cardiovascular Interventions.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top